Inhibition by N-(4-hydroxyphenyl) retinamide of exogenous and endogenous liver carcinogenesis in rats

被引:0
|
作者
Nakae, D
Tamura, K
Akai, H
Kobayashi, Y
Horiguchi, K
Denda, A
Konishi, Y
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The effects of N-(4-hydroxyphenyl)retinamide (4-HPR) on diethylnitrosamine (DEN)-initiated exogenous and a choline-deficient, L-amino acid-defined (CDAA) diet-associated endogenous rat liver carcinogenesis were studied. In the exogenous model, male Fischer 344 rats, 6 weeks old, were given 200 mg/kg body weight of DEN, partially hepatectomized on Week 3, and administered 4-HPR at doses of 0, 0.04, 0.08 and 0.16% between Weeks 2 and 8. In the endogenous model, rats were fed the CDAA diet containing 4-HPR for 12 weeks. 4-HPR inhibited development of glutathione S-transferase placental form (GST-P)-positive foci in both models, more prominent in the latter case. 4-HPR also inhibited the induction of hepatocyte necrosis and connective tissue increase caused by the CDAA diet. It is thus indicated for 4-HPR to exert chemopreventive effects against exogenous and endogenous rat liver carcinogenesis.
引用
收藏
页码:1163 / 1166
页数:4
相关论文
共 50 条
  • [21] Stage-specific effect of N-(4-hydroxyphenyl)retinamide on cell growth in squamous cell carcinogenesis
    Kabbout, M
    Hatoum, A
    Abou-Lteif, G
    Chakroun, I
    Homaidan, FR
    Darwiche, N
    MOLECULAR CARCINOGENESIS, 2004, 40 (01) : 12 - 23
  • [22] EFFECTS OF PRETREATMENT WITH THE RETINOID N-(4-HYDROXYPHENYL)-ALL-TRANS-RETINAMIDE AND PHENOBARBITAL ON THE DISPOSITION AND METABOLISM OF N-(4-HYDROXYPHENYL)-ALL-TRANS-RETINAMIDE IN MICE
    HULTIN, TA
    MCCORMICK, DL
    MAY, CM
    MOON, RC
    DRUG METABOLISM AND DISPOSITION, 1988, 16 (06) : 783 - 788
  • [23] EFFECTS OF N-(4-HYDROXYPHENYL)RETINAMIDE SUPPLEMENTATION ON VITAMIN-A METABOLISM
    LEWIS, KC
    ZECH, LA
    PHANG, JM
    CANCER RESEARCH, 1994, 54 (15) : 4112 - 4117
  • [24] LACK OF GENOTOXICITY OF THE CANCER CHEMOPREVENTIVE AGENT N-(4-HYDROXYPHENYL)RETINAMIDE
    PAULSON, JD
    OLDHAM, JW
    PRESTON, RF
    NEWMAN, D
    FUNDAMENTAL AND APPLIED TOXICOLOGY, 1985, 5 (01): : 144 - 150
  • [26] Synthesis and biological activity of glycosyl conjugates of N-(4-hydroxyphenyl)retinamide
    Winum, JY
    Leydet, A
    Seman, M
    Montero, JL
    FARMACO, 2001, 56 (04): : 319 - 324
  • [27] Bioactivities of N-(4-hydroxyphenyl) retinamide and retinoyl beta-glucuronide
    Formelli, F
    Barua, AB
    Olson, JA
    FASEB JOURNAL, 1996, 10 (09): : 1014 - 1024
  • [28] DISPOSITION AND METABOLISM OF N-(4-METHOXYPHENYL)RETINAMIDE (MPR), THE MAJOR METABOLITE OF N-(4-HYDROXYPHENYL)RETINAMIDE (HPR), IN MICE
    HULTIN, TA
    FILLA, MS
    MCCORMICK, DL
    FASEB JOURNAL, 1988, 2 (05): : A1095 - A1095
  • [29] NEUROBLASTOMA CELL APOPTOSIS INDUCED BY THE SYNTHETIC RETINOID N-(4-HYDROXYPHENYL)RETINAMIDE
    DIVINCI, A
    GEIDO, E
    INFUSINI, E
    GIARETTI, W
    INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (03) : 422 - 426
  • [30] N-(4-hydroxyphenyl) retinamide-induced apoptotic effects in human medulloblastoma
    Reedy, CD
    Guttapalli, A
    Vemuri, M
    Adamson, PC
    Sutton, LN
    Phillips, PC
    NEURO-ONCOLOGY, 2004, 6 (04) : 321 - 321